US Patent Issued to Regeneron Pharmaceuticals on March 17 for "Recombinant cell surface capture proteins" (New York, New Jersey Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,326, issued on March 17, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Recombinant cell surface capture proteins" was invented by Dipali Deshpande (White Plains, N.Y.), Gang Chen (Yorktown Heights, N.Y.), Darya Burakov (Yonkers, N.Y.), James Fandl (LaGrangeville, N.Y.), Thomas Aldrich (Yorktown Heights, N.Y.) and Vishal Kamat (Bergenfield, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Recombinant cell surface capture proteins and detection molecules that are useful for isolating and detecting cells that produce a secreted heterodimeric protein of interest (POI) that has an immunoglobulin CH3 domain and/or substituted CH3 ...